These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 24267478

  • 1. The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage.
    Tuskey A, Peura D.
    Arthritis Res Ther; 2013; 15 Suppl 3(Suppl 3):S6. PubMed ID: 24267478
    [Abstract] [Full Text] [Related]

  • 2. HZT-501 (DUEXIS(®); ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis.
    Schiff M, Peura D.
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):25-35. PubMed ID: 22149579
    [Abstract] [Full Text] [Related]

  • 3. A fixed-dose combination ibuprofen and famotidine (Duexis).
    Med Lett Drugs Ther; 2011 Oct 31; 53(1376):85-6. PubMed ID: 22033211
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fixed-dose ibuprofen/famotidine: a review of its use to reduce the risk of gastric and duodenal ulcers in patients requiring NSAID therapy.
    Deeks ED.
    Clin Drug Investig; 2013 Sep 31; 33(9):689-97. PubMed ID: 23881568
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Editorial: single-tablet ibuprofen/double-dose famotidine for reduction of gastric and duodenal ulcers (REDUCE Trials): what can be reduced?
    Chan FK.
    Am J Gastroenterol; 2012 Mar 31; 107(3):387-8. PubMed ID: 22388022
    [Abstract] [Full Text] [Related]

  • 15. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.
    Health Technol Assess; 2007 Dec 31; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [Abstract] [Full Text] [Related]

  • 16. Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy?
    Wu CS, Wang SH, Chen PC, Wu VC.
    Int J Clin Pract; 1998 Oct 31; 52(7):472-4. PubMed ID: 10622088
    [Abstract] [Full Text] [Related]

  • 17. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R, Armstrong D.
    Can J Gastroenterol; 1999 Mar 31; 13(2):135-42. PubMed ID: 10203432
    [Abstract] [Full Text] [Related]

  • 18. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    Chinese Rheumatism Data Center, Chinese Systemic Lupus Erythematosus Treatment and Research Group.
    Zhonghua Nei Ke Za Zhi; 2017 Jan 01; 56(1):81-85. PubMed ID: 28056333
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.